Mindray Medical CFO, Ronald Ede, to Participate as a Panelist at the Financial Times' Global Pharmaceutical and Biotechnology Conference

SHENZHEN, China, Nov. 4 /PRNewswire-Asia/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today that Mr. Ronald Ede, Chief Financial Officer, will participate in a panel discussion at the Financial Times' Global Pharmaceutical and Biotechnology Conference, which will be held at the Millennium Mayfair Hotel in London on November 17-18, 2009.

Mr. Ede will present as a guest panelist during the panel entitled "Exploring New Avenues for Innovation, Growth and Profitability -- The Role of Emerging Markets," which will take place on November 17, 2009 from 3:15-4:15 GMT.

To learn more about the Financial Times' Global Pharmaceutical and Biotechnology Conference, please visit http://www.ftconferences.com/pharmabio .

About Mindray

We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we are able to supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://ir.mindray.com .

For further information, please contact:

In the U.S.:

FD

Evan Smith, CFA

Tel: +1-212-850-5606

Email: evan.smith@fd.com

John Capodanno

Tel: +1-212-850-5705

Email: john.capodanno@fd.com

In China:

Cathy Gao

Tel: +86-755-2658-2518

Email: cathy.gao@mindray.com

SOURCE Mindray Medical International Limited